【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Global Markets Direct Report Coverage 7
Recurrent Glioblastoma Multiforme (GBM) Overview 8
Therapeutics Development 9
Pipeline Products for Recurrent Glioblastoma Multiforme (GBM) – Overview 9
Pipeline Products for Recurrent Glioblastoma Multiforme (GBM) – Comparative Analysis 10
Recurrent Glioblastoma Multiforme (GBM) – Therapeutics under Development by Companies 11
Recurrent Glioblastoma Multiforme (GBM) – Therapeutics under Investigation by Universities/Institutes 15
Recurrent Glioblastoma Multiforme (GBM) – Pipeline Products Glance 16
Late Stage Products 16
Clinical Stage Products 17
Early Stage Products 18
Recurrent Glioblastoma Multiforme (GBM) – Products under Development by Companies 19
Recurrent Glioblastoma Multiforme (GBM) – Products under Investigation by Universities/Institutes 22
Recurrent Glioblastoma Multiforme (GBM) – Companies Involved in Therapeutics Development 23
Agenus, Inc. 23
Amgen Inc. 24
AngioChem Inc. 25
Apogenix GmbH 26
AstraZeneca PLC 27
Axelar AB 28
Boehringer Ingelheim GmbH 29
Boston Biomedical, Inc. 30
Celldex Therapeutics, Inc. 31
e-Therapeutics plc 32
Eisai Co., Ltd. 33
Eli Lilly and Company 34
EnGeneIC Ltd 35
ERC Belgium SA 36
GenSpera, Inc. 37
GlaxoSmithKline plc 38
GW Pharmaceuticals plc 39
ImmunoCellular Therapeutics, Ltd. 40
Karyopharm Therapeutics, Inc. 41
Merck & Co., Inc. 42
Novartis AG 43
OncoEthix SA 44
Ono Pharmaceutical Co., Ltd. 45
Pfizer Inc. 46
Sangamo BioSciences, Inc. 47
Spectrum Pharmaceuticals, Inc. 48
Threshold Pharmaceuticals, Inc. 49
Tocagen Inc. 50
Vascular Biogenics Ltd. 51
Virttu Biologics Limited 52
ZIOPHARM Oncology, Inc. 53
Recurrent Glioblastoma Multiforme (GBM) – Therapeutics Assessment 54
Assessment by Monotherapy Products 54
Assessment by Combination Products 55
Assessment by Target 56
Assessment by Mechanism of Action 60
Assessment by Route of Administration 63
Assessment by Molecule Type 65
Drug Profiles 67
(GWP-42002 + GWP-42003) – Drug Profile 67
Ad-RTS-IL-12 – Drug Profile 68
afatinib – Drug Profile 70
AMG-595 – Drug Profile 74
ANG-1005 – Drug Profile 76
APG-101 – Drug Profile 78
axitinib – Drug Profile 80
AXL-1717 – Drug Profile 83
AZD-7451 – Drug Profile 85
BBI-608 – Drug Profile 86
BGJ-398 – Drug Profile 89
bosutinib – Drug Profile 90
buparlisib hydrochloride – Drug Profile 92
capmatinib – Drug Profile 96
dacomitinib – Drug Profile 98
Dendritic Cell Therapy for Recurrent Glioblastoma Multiforme – Drug Profile 100
DNX-2401 – Drug Profile 101
doxorubicin – Drug Profile 103
ERC-1671 – Drug Profile 104
erismodegib – Drug Profile 106
ETS-2101 – Drug Profile 109
evofosfamide – Drug Profile 111
G-200 – Drug Profile 118
galunisertib – Drug Profile 120
golvatinib + lenvatinib – Drug Profile 122
HSV-1716 – Drug Profile 124
ICT-121 – Drug Profile 127
lonafarnib – Drug Profile 128
MDNA-55 – Drug Profile 130
mipsagargin – Drug Profile 131
nabiximols – Drug Profile 133
nivolumab – Drug Profile 136
Oncolytic Virus for Oncology – Drug Profile 142
Oncolytic Virus to Target IL-12 for Oncology – Drug Profile 143
ortataxel – Drug Profile 144
OS-2966 – Drug Profile 145
OTX-015 – Drug Profile 146
pazopanib hydrochloride – Drug Profile 148
pembrolizumab – Drug Profile 153
ribociclib – Drug Profile 158
rilotumumab – Drug Profile 161
rindopepimut – Drug Profile 163
SB-313 – Drug Profile 165
selinexor – Drug Profile 166
SGT-53 – Drug Profile 170
TPI-287 – Drug Profile 172
trebananib – Drug Profile 174
Vaccine to Target Carcinoembryonic Antigen for Oncology – Drug Profile 177
vandetanib – Drug Profile 178
VB-111 – Drug Profile 184
vocimagene amiretrorepvec + flucytosine ER – Drug Profile 185
Recurrent Glioblastoma Multiforme (GBM) – Recent Pipeline Updates 187
Recurrent Glioblastoma Multiforme (GBM) – Dormant Projects 274
Recurrent Glioblastoma Multiforme (GBM) – Discontinued Products 275
Recurrent Glioblastoma Multiforme (GBM) – Product Development Milestones 276
Featured News & Press Releases 276
Appendix 283
Methodology 283
Coverage 283
Secondary Research 283
Primary Research 283
Expert Panel Validation 283
Contact Us 283
Disclaimer 284
【レポート販売概要】
■ タイトル：再発性多形性膠芽腫(Recurrent Glioblastoma Multiforme (GBM))：治療薬開発パイプライン動向（2015年上半期版）■ 英文：Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015
■ 発行日：2015年3月11日
■ 調査会社：Global Markets Direct
■ 商品コード：GMDHC6256IDB
■ 調査対象地域：グローバル
- スペインの自動微生物検査市場2014Complete report $6,950. DataPack (test volumes, sales forecasts, supplier shares) $4,500. “Spanish Automated Microbiology Market 2014” is a new analysis of major business opportunities emerging in the Spanish automated microbiology market during the next five years. The report examines key trends, reviews current and emerging assays; analyzes potential applications of …
- Freehold Royalties Ltd.：石油・ガスの開発・生産動向及びコスト分析- Q3, 2013Freehold Royalties Ltd. Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Freehold Royalties Ltd. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential so …
- 淡水化装置の世界市場分析The global water desalination equipment market value is anticipated to reach USD 25.1 billion by 2025, according to a new report by Grand View Research, Inc. Growing demand for water, increasing water need in industries, and rising population are expected to influence product demand over the forecast period. In the past few years, the industry has witnessed increasing investments in R&D activities …
- ソーヤ・レシチンの世界市場Soya Lecithin (CAS 8002-43-5) Market Research Report 2013 presents comprehensive data on Soya lecithin markets globally and regionally (Europe, Asia, North America etc.) The Soya Lecithin (CAS 8002-43-5) Market Research Report 2013 includes Soya lecithin description, covers its application areas and related patterns. It overviews Soya lecithin market, names Soya lecithin producers and indicates it …
- Pengrowth Energy Corporation社の石油・ガス開発・生産動向及びコスト分析（2013年第4四半期）Pengrowth Energy Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2013 Summary Pengrowth Energy Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an es …
- ロイヤルティ管理ソリューションの世界市場：カスタマー・ロイヤルティ、人材リテンション、チャネル・ロイヤルティThis report on loyalty management software-based solutions estimates the market to grow from USD 1.4 Billion in 2015 to USD 4.0 Billion by 2020, at a CAGR of 23.2% during the forecast period. The increased focus of organizations on customer segmentation has pushed the loyalty management solution vendors to provide better solutions for effective end-to-end management of customer loyalty programs. U …
- 防曇添加剤の世界市場：グリセロールエステル、ポリグリセロールエステル、ソルビタン脂肪酸エステル、エトキシル化ソルビタンエステル、オレイン酸ポリオキシエチレンエステル、ゼラチン、二酸化チタンThe global antifog additives market is projected to reach USD 1.74 Billion by 2020, at a CAGR of 7.3% between 2015 and 2020. Rising demand for antifog additive films from the food packaging and agricultural sectors and the increasing demand for packed food items are major factors influencing the growth of this market. Among all applications, the food packaging films segment led the global antifog …
- 再生可能化学物質の世界市場：アルコール、生体高分子、プラットフォームケミカルThe global renewable chemicals market is estimated to be USD 49.0 Billion in 2015 and is projected to reach USD 84.3 Billion by 2020, at a CAGR of 11.47% between 2015 and 2020. The renewable chemicals market has been majorly segmented into alcohols, platform chemicals, and biopolymers. The alcohols accounts for more than 80.0% of the renewable chemicals market, in terms of value in 2015 and the sa …
- 欧州主要国の心臓血管外科用機器市場見通し（～2021）EU5 Cardiovascular Surgery Outlook to 2021 Summary GlobalData’s new report, "EU5 Cardiovascular Surgery Outlook to 2021", provides key procedures data on the EU5 Cardiovascular Surgery. The report provides procedure volumes within market segments - Coronary Artery Bypass Graft (CABG) Procedures and Isolated Valve Procedures. The data in the report is derived from dynamic market forecast models. Gl …
- UAVドローンの世界市場：固定翼ドローン、回転翼ドローン、ナノドローン、ハイブリッドドローンThe scope of the report comprises a study of small unmanned aerial vehicles designed to be used in various commercial applications such as media and entertainment, precision agriculture, inspection, surveying among others. With the relaxations in government policies and increase in number of exceptions granted to the companies for the commercial use of UAV drones, the drones market is expected to …
- 世界の感染症検査市場This new 950-page report from VPGMarketResearch provides analysis of the global infectious disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, and strategic profiles of leading suppliers. The report presents: Estimated numbers of infectious disease testing laboratories, as well as test volume and sales forecasts for France, Germany, It …
- ディーゼルエンジンの世界市場2016-2020About Diesel Engines The diesel engine is an internal combustion engine in which air is compressed inside the cylinder to ignite the fuel. Two main types of diesel engines are available in the market. They are two-stroke and four-stroke engines. Diesel engines are capable of offering better operational performance, which makes them a preferred choice over petrol engines. The market is expected to …
- ICT予算及び人員配置動向：ユーティリティー産業部門 – 企業のICT投資計画Why was the report written? In order to provide a depth of insight into ICT vendors’ and service providers’ potential customers. What is the current market landscape and what is changing? According to Kable’s survey, the allocation of ICT budgets to hardware and services is expected to remain at the same level in 2013 as in 2012, whilst the budget allocation for software is expected to increase ov …
- ビックデータビジネス：経営者及びITリーダー向けの市場分析Most of business people are aware of market analysis and its importance to the business. The process of market analysis has been carried out over decades by highly paid experts who enhanced the business leaders’ knowledge of the market as an approach to improve the decision taking. Therefore, many business executives today believe that the Big Data technology is just a step to boost the business a …
- 世界のデジタルマップ市場動向（2012-2016）TechNavio's analysts forecast the Global Digital Map market to grow at a CAGR of 13.93 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increased adoption of digital maps in the Automobile industry. The Global Digital Map market has also been witnessing an increasing development of 3D maps. However, the requirement of large resources for surveying …
